Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zymeworks (ZYME) Operating Expenses (2021 - 2025)

Zymeworks' Operating Expenses history spans 5 years, with the latest figure at $46.7 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 12.36% to $46.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $198.5 million, a 6.98% decrease, with the full-year FY2025 number at $198.5 million, down 6.98% from a year prior.
  • Operating Expenses hit $46.7 million in Q4 2025 for Zymeworks, down from $49.7 million in the prior quarter.
  • Over the last five years, Operating Expenses for ZYME hit a ceiling of $83.1 million in Q4 2022 and a floor of $40.3 million in Q4 2023.
  • Historically, Operating Expenses has averaged $57.4 million across 5 years, with a median of $53.1 million in 2022.
  • Biggest five-year swings in Operating Expenses: surged 36.86% in 2022 and later tumbled 51.45% in 2023.
  • Tracing ZYME's Operating Expenses over 5 years: stood at $60.7 million in 2021, then soared by 36.86% to $83.1 million in 2022, then tumbled by 51.45% to $40.3 million in 2023, then soared by 31.98% to $53.2 million in 2024, then decreased by 12.36% to $46.7 million in 2025.
  • Business Quant data shows Operating Expenses for ZYME at $46.7 million in Q4 2025, $49.7 million in Q3 2025, and $49.4 million in Q2 2025.